-
Most Recent
coronavirus
With New Subscription Service Rollout, It’s Time to Take Walmart Seriously
WMT stock was already attractive for the dividends and as a safety-minded investment. The newly announced subscription service only adds to its value.
Evolving eBay Will Continue to Post Strong Growth Numbers
It's not as flashy as newer e-commerce names, so eBay has a tendency to be overlooked. But you shouldn't discount EBAY stock right now.
Big Catalysts Are Just Around the Corner for iBio Stock
Asset prices don't go up in a straight line, even if the company shows promise. Use the dip in IBIO stock now to get in at a favorable price.
Even After Bankruptcy, Don’t Buy Whiting Petroleum Stock
WLL stock isn't a buy now, and it won't be post-bankruptcy. The company has no play on renewable and weak oil prices will persist for a while.
Moderna Stock Has a Bright Future After the Coronavirus
Moderna is an underdog in the race to develop a coronavirus vaccine, but MRNA stock could benefit from its novel drug discovery technology.
A Single Exemplary Quarter Won’t Fix Rite Aid’s Problems
RAD stock spiked after fiscal first quarter earnings last month. But that good news is offset by worrisome trends facing the sector as a whole.
You Can Breathe Easy With XpresSpa Stock
Sure, XpresSpa made a pretty significant pivot at the start of the pandemic. But for bulls, the pivot creates a nice opportunity in XSPA stock.
Hologic Stock Rides High on Strength of Coronavirus Testing
Hologic has carved out a meaningful niche in women's health. But it's coronavirus testing driving HOLX stock higher these days.
Alibaba Stock Is A Buy No Matter Who the President Might Be
Alibaba is a global powerhouse that mirrors multiple FAANG stocks in a single entity. So why doesn't BABA stock trade higher?
Be Careful with Novavax and the Recent Surge in NVAX Stock
Covid-19 vaccine stocks are on fire, but many of them appear to be out over their skis, including the group's hottest name, NVAX stock.
Tread Carefully With INO Stock, Because Inovio Is Far From a Sure Thing
Covid-19 vaccine stocks are red-hot right now thanks to the emergence of a second wave, but I'd be careful chasing this rally in INO stock.